SFL’s Head of Combination Products Theresa Jeary and Head of Medical Devices Karin Schulze are providing training at the Medtech&Pharma Platform course entitled “Overview of key requirements for combination and substance-based products under MDR” (27^th November, 2019, Basel). The course provides an overview of the MDR’s regulatory system and emphasizes the implementation requirements to keep processes and portfolios compliant, and products on the market when the MDR finally replaces the existing Medical Device Directive (MDD) legislation in spring 2020.

SFL’s experienced medical device and combination products team can support your various MDR implementation projects by performing MDR gap analyses, proposing effective strategies to achieve MDR compliance and providing hands-on support with all aspects of MDR implementation. Please contact us to discuss your projects.